|
Mr. Gooding is a Venture Partner at the Aurora Funds and also serves as President of Regado Biosciences, an Aurora’s portfolio company. As a Venture Partner for Aurora, he works primarily with Aurora's life science portfolio, specifically in the areas of biotechnology, drug discovery and development. Mr. Gooding currently services on the Boards of both Cropsolution and Metabolon. Prior to joining Aurora in 2001, he was a Director of Business Development at Paradigm Genetics (now Icoria, Inc.: ICOR). Mr. Gooding also spent four years at Incyte Pharmaceuticals (INCY), where he was the manager of the cDNA Library Construction Group. In addition, he worked as a Research Associate at Stratagene Cloning Systems in La Jolla, California. Mr. Gooding received a Bachelor of Arts in Biology, with a minor in Chemistry, from the University of San Diego and an MBA from the Kenan-Flagler Business School in Chapel Hill, NC. | 